Abstract |
Aberrant expression of cell cycle regulators have been implicated in prostate cancer development and progression. Therefore, understanding transcriptional networks controlling the cell cycle remain a challenge in the development of prostate cancer treatment. In this study, we found that icilin, a super-cooling agent, down-regulated the expression of cell cycle signature genes and caused G1 arrest in PC-3 prostate cancer cells. With reverse-engineering and an unbiased interrogation of a prostate cancer-specific regulatory network, master regulator analysis discovered that icilin affected cell cycle-related transcriptional modules and identified E2F1 transcription factor as a target master regulator of icilin. Experimental analyses confirmed that icilin reduced the activity and expression levels of E2F1. These results demonstrated that icilin inactivates a small regulatory module controlling the cell cycle in prostate cancer cells. Our study might provide insight into the development of cell cycle-targeted cancer therapeutics.
|
Authors | Sanghoon Lee, Jung Nyeo Chun, Su-Hwa Kim, Insuk So, Ju-Hong Jeon |
Journal | Biochemical and biophysical research communications
(Biochem Biophys Res Commun)
Vol. 441
Issue 4
Pg. 1005-10
(Nov 29 2013)
ISSN: 1090-2104 [Electronic] United States |
PMID | 24239550
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier Inc. All rights reserved. |
Chemical References |
- DNA, Superhelical
- E2F1 Transcription Factor
- Pyrimidinones
- icilin
|
Topics |
- Cell Cycle
(drug effects, genetics)
- Cell Line, Tumor
- DNA, Superhelical
(drug effects)
- E2F1 Transcription Factor
(antagonists & inhibitors)
- Humans
- Male
- Prostatic Neoplasms
(genetics, pathology)
- Pyrimidinones
(pharmacology)
|